The two groups of countries disagree with
respect to trends. In the east and south the public
sector has lost share in 8 of the 11 countries,
usually by a small margin. The reverse has
occurred in the west and central, where the public
sector has gained in 9 of the 13 countries, often by
a large margin. There the figures are somewhat
unstable since the base of users is small.
Especially in places where the total users of the
injectable are still few, or where at least the private
market is still small, commercial firms may see
very little potential in expanding their distribution
to pharmacies or private medical firms.